Time-adjusted Analysis Shows Weak Associations Between BCG Vaccination Policy and COVID-19 Disease Progression
Bodova, K.; Boza, V.; Brejova, B.; Kollar, R.; Mikusova, K.; Vinar, T.
Show abstract
In this study, we ascertain the associations between BCG vaccination policies and progression of COVID-19 through analysis of various time-adjusted indicators either directly extracted from the incidence and death reports, or estimated as parameters of disease progression models. We observe weak correlation between BCG vaccination status and indicators related to disease reproduction characteristics. We did not find any associations with case fatality rates (CFR), but the differences in CFR estimates are at present likely dominated by differences in testing and case reporting between countries.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A novel cohort analysis approach to determining the case fatality rate of COVID-19 and other infectious diseases 91%
- The lower COVID-19 related mortality and incidence rates in Eastern European countries are associated with delayed start of community circulation 90%
- Characteristics and outcome profile of Hospitalized African COVID-19 patients: The Ethiopian Context 90%
Similar papers in this journal
- The Long-Term Impact of COVID-19 Non-Pharmaceutical Interventions on Notifiable Infectious Diseases in Poland: A Comprehensive Analysis from 2014-2022 91%
- Tuberculosis diagnosis cascade in Blantyre, Malawi: a prospective cohort study 91%
- Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 91%
Similar papers in this journal
- Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina 91%
- Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 14th and 28th day of the disease course: a retrospective cohort study in Bangladesh 90%
- Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection 90%
Similar papers in this journal
- Factors associated with the decay of anti-SARS-CoV-2 neutralizing antibodies among recipients of an adenoviral vector-based AZD1222 and a whole-virion inactivated (BBV152) vaccine in Chennai, India: a prospective, longitudinal, cohort study 90%
- Characterization of SARS-CoV-2 vaccine waning in Mexico 90%
- Growth rate and acceleration analysis of the COVID-19 pandemic reveals the effect of public health measures in real time 89%
Similar papers in this journal
- Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China 91%
- Country differences in transmissibility, age distribution and case-fatality of SARS-CoV-2: a global ecological analysis 90%
- Vaccine effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine against reported SARS-CoV-2 Delta and Omicron infection among adolescents, Norway, August 2021 to January 2022 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.